Clinical Trial Update: Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I [Phase 3]

View source ↗

Summary

Phase 3 trial update on intensive lipid elimination regimen for acute coronary syndrome, reporting plaque regression and progenitor cell mobilization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: VA Office of Research and Development | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2019-07-15